Crossmark

Identification of human glutaminyl cyclase inhibitors for Alzheimer’s disease: integrating virtual screening, DFT calculations, and molecular dynamics simulation

Crossref DOI link: https://doi.org/10.1007/s11696-025-04530-6

Published Online: 2025-12-08

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Jingjing

Wei, Chaochun

Zhang, Xiaokun

Zhong, Qidi

Yan, Hong

Wang, Juan
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (31970044)

National Natural Science Foundation of China (32370805)
License Information

Text and Data Mining valid from 2025-12-08

Version of Record valid from 2025-12-08
More Information

Article History

Received: 10 December 2024

Accepted: 15 November 2025

First Online: 8 December 2025

Declarations

:

: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Document is current

Any future updates will be listed below